Skip to content
Clinical Documentation

Discover the Future of Clinical Documentation: Frost Radar™ 2025 Identifies the CDI Leaders Redefining Healthcare

Why This Analysis Matters

As healthcare shifts from fee-for-service to value-based models, Clinical Documentation Integrity (CDI) has emerged as a strategic pillar. More than just a compliance tool, CDI now plays a key role in improving care quality, boosting operational efficiency, and ensuring reimbursement accuracy.

This Frost & Sullivan analysis brings you a first look at the vendors driving the next wave of CDI transformation.

What’s Inside the Frost Radar™ Analysis?

In this exclusive 2025 edition of the Frost Radar™, we:

  • Benchmarked 120+ vendors and spotlighted the top 11 industry leaders

  • Evaluated innovation across AI, ambient scribing, NLP, and autonomous coding

  • Scored vendors on growth, scalability, and tech strategy

  • Provided tactical insights for providers, partners, and investors shaping the CDI roadmap

Download Sample

Top Companies to Watch

Featured vendors include:

  • Microsoft – Leading with ambient AI and cloud-native CDI tools

  • Optum – Pioneering enterprise-scale NLP and clinical intelligence

  • Oracle Health, Solventum, Iodine Software, Arintra – Redefining automation and provider experience

Whether you are building a next-gen CDI tech stack, exploring partnerships, or seeking to stay ahead of the curve, this analysis offers strategic clarity for your next move.

Strategic Insights You Will Gain

Technology Intelligence

•    First-in-human milestones (e.g., ChampioNIR, Esprit BTK)

•    R3 Vascular’s IDE-backed MAGNITUDE trial

•    Positive long-term results from Abbott’s bioresorbable portfolio

Opportunities to Act On

•    Growth in below-the-knee interventions for chronic limb-threatening ischemia (CLTI)

•    Clinical adoption in ambulatory surgical centers (ASCs)

•    Innovation gaps in resorbable scaffolds and device-drug synergy

Competitive Landscape

•    Market share and positioning of Boston Scientific, Abbott, BD, Medtronic, and emerging disruptors

•    Strategic M&A activity: Acotec, Cardiovascular Systems Inc.

Sign up for a complimentary Growth Pipeline Dialog™

A Growth Pipeline Dialog is a structured discussion with our growth experts providing unparalleled technology intelligence and proven implementation best practices. This discussion will spark innovative thinking and help generate a pipeline of growth opportunities you can leverage to maximize your company’s future growth potential.

Upon completing the dialog session, you will receive a $1,000 honorarium* as a token of our appreciation, which can be used towards the purchase of our products and services on store.frost.com.

*$1,000 honorarium is subject to eligibility

drive-growth-image-scaled-2